For example, when the paediatric flu vaccine ran out—this is the one that you can pay for privately as a parent—what did big pharma do? Try and get more vaccines? No, they increased the price—they increased the price to manage their inventory. There's something very wrong with that, and that's only discoverable through an Official Information Act (OIA) request—with Pharmac, actually. There's something very wrong with that—that, as the paediatric flu vaccine was running out, big pharma, the sole supplier, increased their price to maintain their inventory. They didn't manage the children; they managed their inventory. Surely, our mission is to vaccinate more children. Their greater task was to get more vaccines in, not to increase the price—as Pharmac said in the OIA, they successfully managed their inventory by increasing the price. That's a perverse behaviour; that's not a good behaviour. I'm very uncomfortable with that, and I suspect we've seen parts of that through coronavirus as well.